Focus on clinical research:
- Diagnostics, prognosis and therapy improvement in AML
- Diagnostics, prognosis and therapy improvement in CML
- Prognostic factors and therapy improvement in MDS
- Diagnostics, prognosis and therapy improvement in mastocytosis
- Therapy improvement in clinical haematology at an advanced age
- Establishment of personalized medicine for myeloid neoplasms
Focus on basic research:
- Basophilic granulocytes and tissue mast cells
- Pathophysiology of AML, CML, MDS and mastocytoses
- Eosinophilic granulocytes and eosinophilic leukemias
- Oncogene-dependent signal transduction in leukemia cells
- Identification of new therapeutic targets in neoplastic cells
- Characterization and eradication of leukemic stem cells
- Synergistic effect of new antileukemic drugs
Coordination of networks:
- European Competence Network for Mastocytosis (ECNM)
- International Cooperative Working Group on Eosinophilic Diseases (ICOG-EO)
- Special Research Area (SFB) Myeloproliferative Neoplasia (SFB-F47)
- Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO)
- Clinical Center of Excellence of the MDS Foundation
- Center of Excellence and Reference Center of the ECNM
Awards/Honours:
- 1989: Paracelsus Award of the Austrian Society for Internal Medicine
- 1989: Karl Landsteiner Award of Austr. Soc. f. Allergol. and Immunology
- 1990: Hoechst Company Award
- 1991: Wilhelm Türk Award of the Austr. Soc. f. Hematology and Oncology
- 1991: Theodor Billroth Award of the Vienna Medical Council
- 1992: Hoechst Company Award
- 1992: Denk Award of the Austr. Soc. f. Hematology and Oncology
- 1992: Austrian Sandoz Award
- 1994: Denk Award of the Austr. Soc. f. Hematology and Oncology
- 1995: Theodor Billroth Award of the Vienna Medical Council
- 1995: Mack Forster Award of the European Soc. for Clinical Investigation
- 2006: Middle European Award for Interdisciplinary Cancer Research